RxDoctor Payments Data

Daniel Prince, MD

Orthopaedic Surgery · New York, NYNPI 1376700013

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (40.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Globus Medical accounts for 88.2% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $2,905 and has fallen 55.2% since, to $1,301 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in NY, where the typical reported total is $4,024.

$4,587in general payments, 2019–2025

Across 14 payments — averaging $327.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$4K
  • Arteriocyte Medical Systems, Inc.$196
  • Stryker$172
  • Onkos Surgical, Inc.$124
  • Solventum Corporation$20
  • Bioventus LLC$18
  • plus $12 from 1 others

What the payments were for

  • Consulting fees$1,87541%
  • Travel & lodging$1,71337%
  • Food & beverage$99922%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,587 in reported general payments places this provider in the 50th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024
$59,262
Medicare patients
81
Services billed
199

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →